In Vitro Drug-Drug Interaction Evaluation of GalNAc Conjugated siRNAs Against CYP450 Enzymes and Transporters-Reference-Cited by-同舟云学术

In Vitro Drug-Drug Interaction Evaluation of GalNAc Conjugated siRNAs Against CYP450 Enzymes and Transporters

Published:2019-07-03 Issue:10 Volume:47 Page:1183-1194
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Ramsden Diane^ORCID,Wu Jing-Tao,Zerler Brad,Iqbal Sajida,Jiang Jim,Clausen Valerie,Aluri Krishna^ORCID,Gu Yongli,Dennin Sean,Kim Joohwan,Chong Saeho

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference39 articles.

1. Capacity limits of asialoglycoprotein receptor-mediated liver targeting;Bon;MAbs,2017

2. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

3. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

4. Application of Receiver Operating Characteristic Analysis to Refine the Prediction of Potential Digoxin Drug Interactions

5. European Medicines Agency (2012) Guideline on the Investigation of Drug Interactions, Committee for Medicinal Products for Human Use, European Medicines Agency, London.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study on the molecular interactions between givosiran and theophylline by surface-enhanced Raman spectroscopy, biolayer interferometry, and visible/fluorescence spectroscopy;Microchemical Journal;2024-08

2. Metabolite identification and quantitation of RBD1016 siRNA: a direct comparison of hybridization-based LC-FD and LC-HRAM assays;Bioanalysis;2024-01

3. Biotransformation research advances – 2022 year in review;Drug Metabolism Reviews;2023-10-02

5. Pharmacokinetics and Pharmacodynamics of GalNAc‐Conjugated siRNAs;The Journal of Clinical Pharmacology;2023-09-02